Salix (SLXP) Falls 23 percent

Salix Pharmaceutics Ltd. (SLXP) tumbled 23% to $32.14 for the biggest retreat in the Russell 2000 Index. The drugmaker said the FDA wasn’t ready to approve at this time its Xifaxan drug for treating non-constipation irritable bowel syndrome without more information.

Be the first to comment

Leave a Reply

Your email address will not be published.